Brecher P, Tercyak A, Chobanian A V
Hypertension. 1981 Mar-Apr;3(2):198-204. doi: 10.1161/01.hyp.3.2.198.
Angiotensin-converting enzyme (ACE) was studied in preparations of microvessels isolated from rabbit cerebral cortex. Activity was determined by measuring the degradation of hippuryl-histidyl-leucine (Hip-His-Leu) by the intact microvessels in a physiological salt solution at pH 7.4. ACE activity was dependent on both substrate and chloride ion concentration and was inhibited by captopril in a manner similar to that observed previously with tissue homogenates. Angiotensin I was rapidly degraded by the intact microvessels, even in the presence of 10(-6)M captopril. An advantage of the methodology employed was the ability to pretreat the microvessels and then assess the effect of pretreatment by transfer to a postincubation assay system. Pretreatment with a hyperosmolar urea solution did not change ACE activity or cause release of ACE from the microvessels, although lactic dehydrogenase and lysosomal enzymes were released. Pretreatment with captopril caused a lag in the subsequent degradation of Hip-His-Leu, presumably reflecting dissociation of inhibitor from the cell-associated enzyme. ACE activity was unaffected by hypoxic or anoxic incubation conditions. The ability to measure ACE activity of the microvessels in vitro provides a unique opportunity to study the properties of the enzyme in intact cerebrovascular endothelial cells.
在从兔大脑皮层分离出的微血管制剂中对血管紧张素转换酶(ACE)进行了研究。通过在pH 7.4的生理盐溶液中测量完整微血管对马尿酰 - 组氨酰 - 亮氨酸(Hip - His - Leu)的降解来确定活性。ACE活性既取决于底物又取决于氯离子浓度,并且被卡托普利抑制,其方式与先前在组织匀浆中观察到的相似。即使在存在10⁻⁶M卡托普利的情况下,血管紧张素I也会被完整的微血管迅速降解。所采用方法的一个优点是能够对微血管进行预处理,然后通过转移到孵育后测定系统来评估预处理的效果。用高渗尿素溶液预处理不会改变ACE活性,也不会导致ACE从微血管中释放,尽管乳酸脱氢酶和溶酶体酶会被释放。用卡托普利预处理会导致随后Hip - His - Leu降解出现延迟,推测这反映了抑制剂从细胞相关酶上解离。ACE活性不受缺氧或无氧孵育条件的影响。在体外测量微血管ACE活性的能力为研究完整脑血管内皮细胞中该酶的特性提供了一个独特的机会。